192 related articles for article (PubMed ID: 19763496)
1. Identification of natural human glucocorticoid receptor (hGR) mutations or polymorphisms and their functional consequences at the hormone-receptor interaction level.
Charmandari E; Chrousos GP; Kino T
Methods Mol Biol; 2009; 590():33-60. PubMed ID: 19763496
[TBL] [Abstract][Full Text] [Related]
2. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.
Charmandari E; Kino T; Ichijo T; Zachman K; Alatsatianos A; Chrousos GP
J Clin Endocrinol Metab; 2006 Apr; 91(4):1535-43. PubMed ID: 16449337
[TBL] [Abstract][Full Text] [Related]
4. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
[TBL] [Abstract][Full Text] [Related]
5. Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells.
Jewell CM; Scoltock AB; Hamel BL; Yudt MR; Cidlowski JA
Mol Endocrinol; 2012 Feb; 26(2):244-56. PubMed ID: 22174376
[TBL] [Abstract][Full Text] [Related]
6. A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.
Charmandari E; Ichijo T; Jubiz W; Baid S; Zachman K; Chrousos GP; Kino T
J Clin Endocrinol Metab; 2008 Dec; 93(12):4963-8. PubMed ID: 18827003
[TBL] [Abstract][Full Text] [Related]
7. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
[TBL] [Abstract][Full Text] [Related]
8. Novel causes of generalized glucocorticoid resistance.
Charmandari E; Kino T
Horm Metab Res; 2007 Jun; 39(6):445-50. PubMed ID: 17578762
[TBL] [Abstract][Full Text] [Related]
9. Human glucocorticoid receptor alpha transcript splice variants with exon 2 deletions: evidence for tissue- and cell type-specific functions.
Geng CD; Pedersen KB; Nunez BS; Vedeckis WV
Biochemistry; 2005 May; 44(20):7395-405. PubMed ID: 15895983
[TBL] [Abstract][Full Text] [Related]
10. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.
Charmandari E; Kino T; Ichijo T; Jubiz W; Mejia L; Zachman K; Chrousos GP
J Clin Endocrinol Metab; 2007 Oct; 92(10):3986-90. PubMed ID: 17635946
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid resistance.
Orbak Z
Biochemistry (Mosc); 2006 Oct; 71(10):1073-81. PubMed ID: 17125454
[TBL] [Abstract][Full Text] [Related]
12. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.
Roberts ML; Kino T; Nicolaides NC; Hurt DE; Katsantoni E; Sertedaki A; Komianou F; Kassiou K; Chrousos GP; Charmandari E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E790-5. PubMed ID: 23426617
[TBL] [Abstract][Full Text] [Related]
13. The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes.
Charmandari E; Chrousos GP; Ichijo T; Bhattacharyya N; Vottero A; Souvatzoglou E; Kino T
Mol Endocrinol; 2005 Jan; 19(1):52-64. PubMed ID: 15459252
[TBL] [Abstract][Full Text] [Related]
14. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function.
Oakley RH; Sar M; Cidlowski JA
J Biol Chem; 1996 Apr; 271(16):9550-9. PubMed ID: 8621628
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification and characterization of a and b forms of the glucocorticoid receptor.
Yudt MR; Cidlowski JA
Mol Endocrinol; 2001 Jul; 15(7):1093-103. PubMed ID: 11435610
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the hGRαT556I causing Chrousos syndrome.
Nicolaides NC; Skyrla E; Vlachakis D; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
Eur J Clin Invest; 2016 Jan; 46(1):42-9. PubMed ID: 26541474
[TBL] [Abstract][Full Text] [Related]
17. Enhanced steroid response of a human glucocorticoid receptor splice variant.
Baker AC; Green TL; Chew VW; Tung K; Amini A; Lim D; Cho K; Greenhalgh DG
Shock; 2012 Jul; 38(1):11-7. PubMed ID: 22706020
[TBL] [Abstract][Full Text] [Related]
18. Primary generalized glucocorticoid resistance and hypersensitivity.
Charmandari E
Horm Res Paediatr; 2011; 76(3):145-55. PubMed ID: 21912096
[TBL] [Abstract][Full Text] [Related]
19. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.
Charmandari E; Kino T; Ichijo T; Chrousos GP
J Clin Endocrinol Metab; 2008 May; 93(5):1563-72. PubMed ID: 18319312
[TBL] [Abstract][Full Text] [Related]
20. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action.
Oakley RH; Jewell CM; Yudt MR; Bofetiado DM; Cidlowski JA
J Biol Chem; 1999 Sep; 274(39):27857-66. PubMed ID: 10488132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
